Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QuanDx
San Jose, California, United Statesquandx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
QuanDx has commercialized a portfolio of molecular diagnostic tests for hematological and solid tumor cancers, as well as infectious diseases. Their Q-Fusion leukemia screening kits and MeltPro High Risk HPV Genotyping Assay are in use for clinical diagnostics. The company’s proprietary Yin-Yang Probe technology enables rapid, sensitive, multiplexed detection of genetic markers relevant to personalized medicine[2][3].
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- Diagnostic testMolecular diagnostic kitResearch tool (for nucleic acid detection)
- Industry
- Molecular Diagnostics
02
Partnerships
Zeesan Biotech (collaboration on MeltPro assay)
Beyond the preview
Go deeper on QuanDx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QuanDx.